What's next for checkpoint inhibitors in metastatic urothelial bladder cancer?
Role of BRAF mutation in the treatment for melanoma
BRAF mutated melanoma: targeted or immunotherapy?
Rodabe N. Amaria
The current status of chemotherapy for treating melanoma
Abstracts presented at ASCO 2017: drug re-challenge and pharmacoeconomics